PBM
Propel Bio Management Portfolio holdings
AUM
$82.4M
This Quarter Return
+41.22%
1 Year Return
+29.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$172M
AUM Growth
+$172M
(+42%)
Cap. Flow
-$1.84M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
82.87%
Holding
37
New
3
Increased
5
Reduced
2
Closed
9
Top Buys
| 1 |
Simplify Enhanced Income ETF
HIGH
|
$25.7M |
| 2 |
Achieve Life Sciences
ACHV
|
$11.1M |
| 3 |
Akero Therapeutics
AKRO
|
$5.75M |
| 4 |
Applied Therapeutics
APLT
|
$5.01M |
| 5 |
Phathom Pharmaceuticals
PHAT
|
$4.53M |
Top Sells
| 1 |
Plains GP Holdings
PAGP
|
$21.9M |
| 2 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$21.2M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$5.87M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
$2.13M |
| 5 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$2.13M |
Sector Composition
| 1 | Healthcare | 78.83% |
| 2 | Technology | 1.46% |
| 3 | Energy | 0% |
